Inappropriate Prescribing - First, Do No Harm?
Country of origin: Ireland
Click for Full Details: www.biomedcentral.comInappropriate prescribing (IP) in older patients is highly prevalent and is associated with an increased risk of adverse drug events (ADEs), morbidity, mortality and healthcare utilisation. Consequently, IP is a major safety concern and with changing population demographics, it is likely to become even more prevalent in the future.
In a BMC Geriatrics article Denis O'Mahony and colleagues discuss the causes of IP, screening tools, and prevention of this increasingly important issue.
Click for Full Details: www.biomedcentral.com
Cancer Navigator January 2018
Clinical Pain Advisor January 2018
Endocrinology Advisor January 2018
Breast Cancer Survivor January 2018
Cancer Emergency Response Tool - CERT January 2018
Rheumatology Advisor January 2018
Clinical Advisor January 2018
The Drugs & Bugs app January 2018
Managing Head Injury January 2018
inPracticeŽ Oncology January 2018